Adenoviruses (Ad) are commonly used both experimentally and clinically, including
oncolytic virotherapy applications. In the clinical area, efficacy is frequently hampered by the …

Adenoviral vectors (AdVs) have attracted much attention in the fields of vaccine
development and treatment for diseases such as genetic disorders and cancer. In this …

Pretreatment of B-cell lymphoma patients with immunostimulatory gene therapy using armed
oncolytic viruses may prime tumor lesions for subsequent chimeric antigen receptor (CAR) T …

Human adenoviruses (HAdVs) cause acute respiratory, ocular, and gastroenteric diseases
and are also frequently used as gene and vaccine delivery vectors. Unlike the archetype …

Some viruses (eg, human immunodeficiency virus 1 and severe acute respiratory syndrome
coronavirus 2) have been experimentally proposed to accelerate features of human aging …

Adenoviruses (Ads) are robust vectors for therapeutic applications and vaccines, but their
use can be limited by differences in their in vitro and in vivo pharmacologies. This review …

ABSTRACT Human adenovirus serotype 26 (Ad26) is used as a gene-based vaccine
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV-1 …

Oncolytic viruses (OVs) represent a novel class of cancer immunotherapy agents that
preferentially infect and kill cancer cells and promote protective antitumor immunity …

The incidence of hematological malignancies such as multiple myeloma, leukemia, and
lymphoma has increased over time. Although bone marrow transplantation, immunotherapy …

This review addresses the current status of gene therapy for immunodeficiencies, chronic
granulomatous disease, suicide gene therapy for graft-versus-host disease, viral infections …